The website of the Clinical Services Journal

Study shows myocarditis linked to COVID-19 not as common as believed

A new study suggests myocarditis caused by COVID-19 may be a relatively rare occurrence.

Reports of the rate of COVID-19 myocarditis have varied widely, ranging from 60% among middle-aged and elderly recovered patients to 14% among recovered athletes.

"Although it is clear that COVID-19 impacts the heart and blood vessels, to date, it has been difficult to know how reproducible any changes are due to the relatively small sample size of most autopsy series," notes author, Dr. Vander Heide, Professor and Director of Pathology Research at LSU Health New Orleans School of Medicine. 

Researchers collected data from 277 autopsy cases to analyse cardiovascular pathological findings from patients who died from COVID-19 in nine countries around the world. The data from these autopsied hearts were published in 22 papers. After careful review, the authors determined that the rate of myocarditis found in these patients is between 1.4% and 7.2%. 

"What we have learned is that myocarditis is not nearly as frequent in COVID-19 as has been thought," says Dr. Halushka. "This finding should be useful for our clinical colleagues to reconsider how to interpret blood tests and heart radiology studies."

"By bringing the data together from this large number of autopsy cases, we have better determined the spectrum of histologic findings," adds co-author Dr. Vander Heide, Professor of Pathology at Johns Hopkins University School of Medicine. "Even a low myocarditis rate of 1.4% would predict hundreds of thousands of worldwide cases of myocarditis in severe COVID-19 due to the enormous numbers of infected individuals. Low rates of myocarditis do not indicate that individuals infected with SARS-CoV-2 are not having cardiovascular problems, but rather those complications are likely due to other stressors such as endothelial cell activation, cytokine storms, or electrolyte imbalances."

The authors also created a "checklist" for pathologists to use going forward when evaluating COVID-19 at autopsy to provide consistency in investigating and reporting findings. 

"This study demonstrates the importance of the autopsy in helping us determine what is occurring in the hearts of individuals passing away due to COVID-19," concludes Dr. Halushka.

The findings of the study are published online in Cardiovascular Pathology and are available here.

Upcoming Events

Central Sterilising Club Annual Scientific Meeting

Crowne Plaza, Newcastle Upon Tyne
3rd - 4th April 2023

DECON UK 2023

Hilton Birmingham Metropole
18th April 2023

Infection Prevention and Control 2023

National Conference Centre, Birmingham
25th - 26th April 2023

Oncology Professional Care

ExCeL London E16 1XL
23-24 May 2023

EBME Expo 2023

Judds Lane, Coventry, England, GB, CV6 6
28th - 29th June 2023

AfPP Annual Conference 2023

University of York
10- 13 August 2023

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Upcoming Events

Central Sterilising Club Annual Scientific Meeting

Crowne Plaza, Newcastle Upon Tyne
3rd - 4th April 2023

DECON UK 2023

Hilton Birmingham Metropole
18th April 2023

Infection Prevention and Control 2023

National Conference Centre, Birmingham
25th - 26th April 2023

Oncology Professional Care

ExCeL London E16 1XL
23-24 May 2023

EBME Expo 2023

Judds Lane, Coventry, England, GB, CV6 6
28th - 29th June 2023

AfPP Annual Conference 2023

University of York
10- 13 August 2023

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2023 Step Communications Ltd. Registered in England. Registration Number 3893025